CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-27 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Grant or award · Restricted Stock Units | +24,000 | 24,000 | ||
| 2024-03-27 | Tulipano Stephen J Former CFO | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-03-27 | Tulipano Stephen J Former CFO | Grant or award · Restricted Stock Units | +40,000 | 40,000 | ||
| 2024-03-19 | Tulipano Stephen J CFO | Sale | −4,116 | $6.10 | $25K | 20,746 |
| 2024-03-19 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −4,116 | $6.10 | $25K | 11,469 |
| 2024-03-19 | Nash Huw M. COO & CBO | Sale | −4,116 | $6.10 | $25K | 11,329 |
| 2024-03-19 | Kaye Edward M. MD CEO | Sale | −11,150 | $6.10 | $68K | 69,350 |
| 2024-03-19 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −2,349 | $6.10 | $14K | 7,724 |
| 2024-03-15 | Tulipano Stephen J CFO | Option exercise | +13,100 | 24,862 | ||
| 2024-03-15 | Tulipano Stephen J CFO | Option exercise · Restricted Stock Units | −13,100 | 39,300 | ||
| 2024-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +13,100 | 15,585 | ||
| 2024-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −13,100 | 39,300 | ||
| 2024-03-15 | Nash Huw M. COO & CBO | Option exercise | +13,100 | 15,445 | ||
| 2024-03-15 | Nash Huw M. COO & CBO | Option exercise · Restricted Stock Units | −13,100 | 39,300 | ||
| 2024-03-15 | Kaye Edward M. MD CEO | Option exercise | +35,500 | 80,500 | ||
| 2024-03-15 | Kaye Edward M. MD CEO | Option exercise · Restricted Stock Units | −35,500 | 106,500 | ||
| 2024-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +7,475 | 10,073 | ||
| 2024-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −7,475 | 22,425 | ||
| 2024-03-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +5,504 | $0.60 | $3K | 12,485 |
| 2024-03-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,000 | $7.75 | $77K | 2,485 |
Page 18 of 24 · 461 trades